GMCB Oversight of Drug Prices (S.98) - May 1, 2024
On Tuesday, Nolan Langweil (Principal Fiscal Analyst, Joint Fiscal Office) reviewed S.98 with the House Appropriations Committee. The bill relates to Green Mountain Care Board (GMCB) authority over prescription drug costs. The House Health Care Committee had made amendments concerning the GMCB Nominating Committee, and then passed the bill on to this Committee.